v3.26.3
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 7,029 $ 4,216 $ 18,430 $ 11,292
General and administrative 4,280 2,867 12,760 8,727
Total operating expenses 11,309 7,083 31,190 20,019
Loss from operations (11,309) (7,083) (31,190) (20,019)
Non-operating income:        
Interest income 1,218 292 3,087 814
Total non-operating income 1,218 292 3,087 814
Net loss $ (10,091) $ (6,791) $ (28,103) $ (19,205)
Per share information:        
Net loss per common share, basic (in dollars per share) $ (0.05) $ (0.06) $ (0.15) $ (0.20)
Net loss per common share, diluted (in dollars per share) $ (0.05) $ (0.06) $ (0.15) $ (0.20)
Weighted-average common shares outstanding, basic (in shares) 202,437,078 108,396,260 188,143,803 98,313,970
Weighted-average common shares outstanding, diluted (in shares) 202,437,078 108,396,260 188,143,803 98,313,970